JOHN VIPPERMAN: Open Payments
NPI 1992787980 · CODY, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 82 payments from 26 companies in 2025. Trend: 2023 $1,010 · 2024 $2,024 · 2025 $1,803
Food & beverage: $1,604Education: $199
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $202 |
| AstraZeneca Pharmaceuticals LP | 10 | $191 |
| Incyte Corporation | 4 | $162 |
| PharmaEssentia USA Corporation | 2 | $144 |
| Janssen Biotech, Inc. | 3 | $140 |
| Tempus AI, Inc | 5 | $121 |
| ARRAY BIOPHARMA INC | 6 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| PFIZER INC. | 7 | $75 |
| Gilead Sciences, Inc. | 4 | $66 |
Products named: KEYTRUDA, BESREMI, XT CDX, DARZALEX, ORGOVYX, Trodelvy, IMFINZI, MONJUVI.
Industry payments across WY — which companies pay providers there.
